HopeStage
Back to overview

Anxiety studies

Topics
More filters

Anxiety

Anxiety conditions involve intense, persistent fears or worries that can interfere with everyday life.

5111studies shown
Showing 2,989-3,000 of 5,111
Drug study icon
CompletedNCT00001482

Lamotrigine or gabapentin for ongoing mood symptoms

About this title

New Drugs in the Treatment of Mood Disorders

Read the official source — NCT00001482
Official study title

Evaluation of Lamotrigine (Lamictal® (Registered Trademark)) Monotherapy and Gabapentin (Neurontin® (Registered Trademark)) Monotherapy in the Treatment of Mood Disorders

This study has finished and is no longer accepting participants.

In Bethesda
Anxiety, SchizophreniaMedication study
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Drug study icon
CompletedACTRN12625000575437

Part A Phase I, Single Ascending Dose study of Agomelatine in Healthy Participants

Official study title

Part A: Phase 1, Single- Ascending Dose Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Agomelatine in Healthy Participants.

This study has finished and is no longer accepting participants.

In Australia
AnxietyInterventional studyAges 18–55
Countries
Australia
Sponsor
Seaport Therapeutics Australia Pty LTD
Drug study icon
CompletedACTRN12625000685415

Part B & Part D: Phase I Single and Multiple-Ascending Dose study of SPT-320 in Healthy Participants

Official study title

Part B & Part D: Phase 1, Double-Blind, Placebo-Controlled, 4-Part, Single- and Multiple-Ascending Dose Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of SPT-320 in Healthy Participants.

This study has finished and is no longer accepting participants.

In Australia
AnxietyInterventional studyAges 18–55
Countries
Australia
Sponsor
Seaport Therapeutics Australia Pty Ltd
Drug study icon
CompletedACTRN12625001137482

Part C: A Phase 1 study to assess the effect of food on SPT-320 in Healthy Participants.

Official study title

Part C: Phase 1, Double-Blind, Placebo-Controlled, 4-Part, Single- and Multiple-Ascending Dose Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of SPT-320 in Healthy Participants

This study has finished and is no longer accepting participants.

In Australia
AnxietyInterventional studyAges 18–55
Countries
Australia
Sponsor
Seaport Therapeutics Australia Pty lTD
Behavioral study icon
CompletedACTRN12616001726448

PEARL - Program Enhancing Adjustment to Residential Living

Official study title

A cluster RCT of a novel psychological intervention to reduce depression among at-risk older adults transitioning to residential aged care

This study has finished and is no longer accepting participants.

In Australia
Anxiety, DepressionInterventional studyAges 60+
Countries
Australia
Sponsor
Dr Tanya Davison
Behavioral study icon
WithdrawnACTRN12623000318684

of a group cognitive behavioural therapy (CBT) program for trans young people experiencing minority stress

Official study title

Evaluation of a group cognitive behavioural therapy (CBT) program for trans young people experiencing minority stress: A pilot randomised controlled trial of the Trans Adolescent Group ThErapy for Alleviating Minority stress (TAG TEAM) intervention

This study was withdrawn before enrollment.

In Parkville
Anxiety, DepressionInterventional studyAges 14–16
Countries
Australia
Sponsor
Murdoch Children's Research Institute
Other study type icon
Active Not RecruitingACTRN12616000238471

Study evaluating the Every Moment program for foster and kinship carers of children with challenging behavioural and/or mental health needs

Official study title

Pilot study evaluating the efficacy of the Every Moment program for foster and kinship carers of children with challenging behavioural and/or mental health needs.

This study is no longer accepting new participants.

In Australia
Anxiety, DepressionInterventional studyAges 25+
Countries
Australia
Sponsor
University of Technology Sudney
Other study type icon
CompletedACTRN12624000587505

Study: Response to Stress and Relaxation in Healthy Adults

Official study title

Pilot Study Investigating Relationship between Habitual Diet and Response to Acute Stress or Relaxation in Healthy Adults

This study has finished and is no longer accepting participants.

In New Zealand
AnxietyInterventional studyAges 18–35
Countries
New Zealand
Sponsor
The New Zealand Institute for Plant & Food Research

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.